Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 1
1964 2
1967 2
1968 4
1969 2
1970 1
1971 1
1973 2
1974 1
1975 1
1979 1
1981 1
1983 1
1984 2
1987 1
1988 2
1989 6
1990 7
1991 1
1992 1
1993 3
1994 1
1995 2
1996 4
1997 5
1998 7
1999 10
2000 4
2001 4
2002 5
2003 1
2004 1
2005 2
2006 6
2007 4
2008 6
2009 4
2010 4
2011 2
2013 1
2014 4
2015 4
2016 1
2017 2
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

121 results
Results by year
Filters applied: . Clear all
Page 1
Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic TP53 mutation carriers: a case-controlled study (SIGNIFY).
Bancroft EK, Saya S, Brown E, Thomas S, Taylor N, Rothwell J, Pope J, Chamberlain A, Page E, Benafif S, Hanson H, Dias A, Mikropoulos C, Izatt L, Side L, Walker L, Donaldson A, Cook JA, Barwell J, Wiles V, Limb L, Eccles DM, Leach MO, Shanley S, Gilbert FJ, Gallagher D, Rajashanker B, Whitehouse RW, Koh DM, Sohaib SA, Evans DG, Eeles RA, Walker LG. Bancroft EK, et al. Among authors: Walker L, Walker LG. J Med Genet. 2020 Apr;57(4):226-236. doi: 10.1136/jmedgenet-2019-106407. Epub 2019 Nov 12. J Med Genet. 2020. PMID: 31719169 Free article.
Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?
McBride KA, Ballinger ML, Schlub TE, Young MA, Tattersall MHN, Kirk J, Eeles R, Killick E, Walker LG, Shanley S, Thomas DM, Mitchell G. McBride KA, et al. Among authors: Walker LG. Fam Cancer. 2017 Jul;16(3):423-432. doi: 10.1007/s10689-016-9964-7. Fam Cancer. 2017. PMID: 28124295 Clinical Trial.
Psychosocial morbidity in women with abnormal cervical cytology managed by cytological surveillance or initial colposcopy: longitudinal analysis from the TOMBOLA randomised trial.
Fielding S, Rothnie K, Gray NM, Little J, Cruickshank ME, Neal K, Walker LG, Whynes D, Cotton SC, Sharp L; In association with the TOMBOLA group. Fielding S, et al. Among authors: Walker LG. Psychooncology. 2017 Apr;26(4):476-483. doi: 10.1002/pon.4163. Epub 2016 Jun 14. Psychooncology. 2017. PMID: 27297097 Free PMC article. Clinical Trial.
Long-Term Worries after Colposcopy: Which Women Are at Increased Risk?
Sharp L, Cotton SC, Cruickshank ME, Gray NM, Neal K, Rothnie K, Thornton AJ, Walker LG, Little J; TOMBOLA Group. Sharp L, et al. Among authors: Walker LG. Womens Health Issues. 2015 Sep-Oct;25(5):517-27. doi: 10.1016/j.whi.2015.04.002. Epub 2015 Jun 4. Womens Health Issues. 2015. PMID: 26051021
Women with large (≥3 cm) and locally advanced breast cancers (T3, 4, N1, 2, M0) receiving neoadjuvant chemotherapy (NAC: cyclophosphamide, doxorubicin, docetaxel): addition of capecitabine improves 4-year disease-free survival.
Eremin J, Cowley G, Walker LG, Murray E, Stovickova M, Eremin O. Eremin J, et al. Among authors: Walker LG. Springerplus. 2015 Jan 13;4(1):9. doi: 10.1186/2193-1801-4-9. eCollection 2015. Springerplus. 2015. PMID: 25995984 Free PMC article.
Measuring the psychosocial burden in women with low-grade abnormal cervical cytology in the TOMBOLA trial: psychometric properties of the Process and Outcome Specific Measure (POSM).
Rothnie K, Cotton SC, Fielding S, Gray NM, Little J, Cruickshank ME, Walker LG, Avis M, Sharp L. Rothnie K, et al. Among authors: Walker LG. Health Qual Life Outcomes. 2014;12:154. doi: 10.1186/s12955-014-0154-8. Health Qual Life Outcomes. 2014. PMID: 25767846 Free PMC article.
121 results
Jump to page
Feedback